Talc

CHEMBL3989756 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
379.3 g/mol
LogP
Phase
4

Talc is a hydrated magnesium silicate mineral used medically as a pleurodesis agent, where it is instilled into the pleural space to cause inflammation and adhesion, preventing recurrent pleural effusions. It also serves as an inactive excipient and lubricant in pharmaceutical tablet and powder formulations. Its primary therapeutic application is in managing malignant pleural effusions associated with conditions such as lung cancer.

Berat Molekul

379,2700 g/mol

TPSA

150,00 Ų

Area Terapeutik

Mekanisme Kerja

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O.O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O

InChI

InChI=1S/3Mg.4O2Si.H2O.3O/c;;;4*1-3-2;;;;/h;;;;;;;1H2;;;

Molecular Formula

H2Mg3O12Si4

HBD / HBA

2 / 12

Ikatan yang Dapat Dirotasi

0

Atom Berat

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Talc is a hydrated magnesium silicate mineral used medically as a pleurodesis agent, where it is instilled into the pleural space to cause inflammation and adhesion, preventing recurrent pleural effusions. It also serves as an inactive excipient and lubricant in pharmaceutical tablet and powder formulations. Its primary therapeutic application is in managing malignant pleural effusions associated with conditions such as lung cancer.

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Yes, Talc is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989756. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 165411828. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.